semaglutide and crohn's disease & Disease: Safety & IBD Considerations – PlexusDx GLP-1 and Crohn's Disease: Safety

Los medicamentos GLP-1 no cambian el hecho de que el cuerpo todava requiera una ingesta diaria constante de macronutrientes y micronutrientes importantes como protenas, fibra, vitaminas y minerales

We screen for G6PD deficiency, kidney issues, and other contraindications before treatment

Diarrhea or Constipation: Changes in bowel habits can occur as the digestive system adapts to the medication

Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, Besenbacher S, Magnusson G, Halldorsson BV, Hjartarson E, et al

Gizmodo: Just to clarify, one reason why this timing is important is because its unlikely that a GLP-1 related cancer would emerge within just six months to a year of someone taking these drugs, is that right